The EIF4E1B Knockout HAP1 Polyclonal Cells product consists of a CRISPR/Cas9-edited polyclonal population of HAP1 cells carrying targeted disruption of the EIF4E1B gene. This engineered cell pool serves as a loss-of-function model to investigate the role of EIF4E1B in translation initiation regulation without the need for clonal isolation. The polyclonal format provides a genetically heterogeneous knockout background, enabling robust functional studies while minimizing clonal biases.
HAP1 is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia hematopoietic line. It exhibits an adherent, fibroblast-like morphology and retains a mostly haploid karyotype with the exception of chromosome 8. HAP1 cells are widely employed in gene-editing applications and genetic screens due to the ease of generating homozygous knockouts and the simplified genotype-phenotype relationships afforded by haploidy. The cells maintain expression of hematopoietic lineage markers, making them a relevant yet tractable system for studying fundamental cellular processes.
EIF4E1B encodes a testis-enriched cap-binding protein that functions as a translational repressor. It competes with the canonical initiation factor EIF4E for binding to the mRNA 5?? cap and incorporation into the eIF4F complex. By sequestering cap-binding sites, EIF4E1B suppresses global cap-dependent translation and specifically modulates the expression of target mRNAs involved in spermatogenesis. Its activity is regulated by upstream signals including follicle-stimulating hormone (FSH), androgen receptor, CREM transcription factor, retinoic acid, and MNK kinases. EIF4E1B interacts with core translation machinery components such as eIF4G, EIF4A, and EIF4B, and is modulated by 4E-BP1 and 4E-BP2, which also intersect with the mTOR pathway via RPS6KB1. Downstream, EIF4E1B represses the translation of protamine mRNAs (PRM1, PRM2) and transition nuclear protein mRNAs (TNP1, TNP2), thereby coordinating translational control during spermatogenesis.
Although EIF4E1B expression is typically restricted to the testis, its knockout in HAP1 cells provides a versatile platform to dissect its cap-binding and translation repression functions in a tractable hematopoietic cell line. The near-haploid genetic background of HAP1 ensures unambiguous genotype-phenotype correlations, facilitating quantitative analysis of translation initiation mechanisms. This model enables researchers to investigate the distinct properties of EIF4E1B relative to EIF4E and other 4E family members, and to explore the interplay between cap-dependent translation and signaling pathways such as mTOR and MNK in a simplified cellular system.
This polyclonal knockout model is suitable for a wide range of applications, including functional characterization of EIF4E1B in translation regulation, comparative studies of 4E family redundancy, and drug screening for translation inhibitors (e.g., 4EGI-1, silvestrol). Researchers can employ techniques such as polysome profiling, m7GTP pull-down assays, puromycin incorporation measurements, co-immunoprecipitation of eIF4F components, and quantitative proteomics to assess changes in translation. Additionally, the cells can serve as a genetic background for generating isogenic lines expressing mutant forms of EIF4E1B. For further details and ordering information, please contact Ascent Research.
